Biomarkers and translational research and precision medicine

12P - HER2DX in HER2-positive (HER2+) Inflammatory Breast Cancer (IBC): a correlative analysis from a phase II clinical trial (ID 232)

Presentation Number
12P
Speakers
  • Adrienne G. Waks (Boston, MA, United States of America)
Authors
  • Filipa Lynce (Boston, MA, United States of America)
  • Fara Brasó-Maristany (Barcelona, Spain)
  • Adrienne G. Waks (Boston, MA, United States of America)
  • Patricia Villagrasa Gonzalez (Barcelona, Spain)
  • Guillermo Villacampa (Barcelona, Spain)
  • Esther Sanfeliu Torres (Barcelona, Spain)
  • Patricia Galván (Barcelona, Spain)
  • Laia Pare Brunet (Barcelona, Spain)
  • Leilani Anderson (Boston, United States of America)
  • Charles M. Perou (Chapel Hill, NC, United States of America)
  • Joel Parker (Chapel Hill, United States of America)
  • Ana Vivancos (Barcelona, Spain)
  • Molly Dilullo (Boston, MA, United States of America)
  • Sonia Pernas Simon (L'Hospitalet de Llobregat, Spain)
  • Eric P. Winer (New Haven, United States of America)
  • Beth Overmoyer (Boston, United States of America)
  • Elizabeth A. Mittendorf (Boston, United States of America)
  • Aleix Prat (Barcelona, Spain)
  • Sara M. Tolaney (Boston, MA, United States of America)
Presentation Topic
Biomarkers and translational research and precision medicine